Ob/Gyn Medical News about Sumatriptan-Naproxen

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Combination Treatment for Menstrual Migraine and Dysmenorrhea Using Sumatriptan-Naproxen: Two Randomized Controlled Trials
Obstetrics and Gynecology, 06/23/09

Mannix LK et al. - Sumatriptan-naproxen provided an effective pain-free response at 2 hours, which was maintained up to 48 hours in menstrual migraineurs with dysmenorrhea. Sumatriptan-naproxen was well-tolerated and resulted in decreased rescue medication use and relief of nonpainful menstrual symptoms.

<< Previous
Triple-Marker Prenatal Screening Program for Chromosomal Defects

Next >>
Parametrial Involvement in Radical Hysterectomy Specimens for...